Leap Therapeutics Inc (NASDAQ:LPTX)
| 2.29 Delayed Data As of 3:59pm ET |  +0.17 / +8.02%Today’s Change | 0.57 Today|||52-Week Range 3.18 | +104.46% Year-to-Date |
Latest LPTX News | Press Releases
No recent news for Leap Therapeutics Inc.
Today’s Trading
| Previous close | 2.12 |
| Today’s open | 2.12 |
| Day’s range | 2.12 - 2.29 |
| Volume | 22,422 |
| Average volume (3 months) | 464,936 |
| Market cap | $75.5M |
Data as of 3:59pm ET, 05/28/2020
Growth & Valuation
| Earnings growth (last year) | +9.96% |
| Earnings growth (this year) | +34.35% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARMPArmata Pharmaceutica... | -0.23 | -5.68% |
| TORCresTORbio, Inc. | +0.10 | +4.76% |
| PTIProteostasis Therape... | -0.17 | -11.41% |
| ---- |
Data as of 4:34pm ET, 05/28/2020
Financials
| Next reporting date | August 6, 2020 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
